Advertisement

Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1

      Abstract

      Math Eq Altered mucosal glycosylation in inflammatory bowel disease and colon cancer could affect mucosal bacterial adherence. This study aimed to quantify and characterize mucosa-associated and intramucosal bacteria, particularly Escherichia coli, in these conditions. Math Eq Mucosa-associated bacteria were isolated, after dithiothreitol mucolysis, from biopsy samples obtained at colonoscopy (Crohn’s disease, n = 14 patients; ulcerative colitis, n = 21; noninflamed controls, n = 24) and at surgical resection (colon cancer, n = 21). Intramucosal bacteria were grown after gentamicin treatment followed by hypotonic lysis. Math Eq Mucosa-associated and intramucosal bacteria were cultured more commonly in Crohn’s disease (79%, P = 0.03; and 71%, P < 0.01, respectively), but not ulcerative colitis (38% and 48%), than in noninflamed controls (42% and 29%) and were commonly cultured from colon cancers (71% and 57%). Mucosa-associated E. coli, which accounted for 53% of isolates, were more common in Crohn’s disease (6/14; 43%) than in noninflamed controls (4/24, 17%), as also were intramucosal E. coli: Crohn’s disease, 29%; controls, 9%. E. coli expressed hemagglutinins in 39% of Crohn’s cases and 38% of cancers but only 4% of controls, and this correlated (P = 0.01) with adherence to the I407 and HT29 cell lines. Invasion was cell-line dependent. E. coli, including nonadherent isolates, induced interleukin-8 release from the cell lines. E. coli adhesins showed no blood group specificity, excepting 1 cancer isolate (HM44) with specificity for the Thomsen-Friedenreich antigen, but they could be blocked by soluble plantain fiber. Math Eq These studies support a central role for mucosally adherent bacteria in the pathogenesis of Crohn’s disease and colon cancer. Soluble plant fibers that inhibit their adherence have therapeutic potential.

      Abbreviations:

      BSM (bovine submaxillary mucin), cnf-1 (cytotoxic necrotizing factor-1), IL (interleukin), PAA (poly[N-(2-hydroxyethyl)acrylamide]), PCR (polymerase chain reaction), TF (Thomsen-Friedenreich blood group)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Darfeuille-Michaud A.
        • Neut C.
        • Barnich N.
        • Lederman E.
        • Di Martino P.
        • Desreumaux P.
        • Gambiez L.
        • Joly B.
        • Cortot A.
        • Colombel J.F.
        Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease.
        Gastroenterology. 1998; 115: 1405-1413
        • Swidsinski A.
        • Ladhoff A.
        • Pernthaler A.
        • Swidsinski S.
        • Loening-Baucke V.
        • Ortner M.
        • Weber J.
        • Hoffmann U.
        • Schreiber S.
        • Dietel M.
        • Lochs H.
        Mucosal flora in inflammatory bowel disease.
        Gastroenterology. 2002; 122: 44-54
        • Boudeau J.
        • Glasser A.-L.
        • Masseret E.
        • Joly B.
        • Darfeuille-Michaud A.
        Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’s disease.
        Infect Immun. 1999; 67: 4499-4509
        • Glasser A.L.
        • Boudeau J.
        • Barnich N.
        • Perruchot M.H.
        • Colombel J.F.
        • Darfeuille-Michaud A.
        Adherent invasive Escherichia coli strains from patients with Crohn’s disease survive and replicate within macrophages without inducing host cell death.
        Infect Immun. 2001; 69: 5529-5537
        • Liu Y.
        • van Kruiningen H.J.
        • West A.B.
        • Cartun R.W.
        • Cortot A.
        • Colombel J.F.
        Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease.
        Gastroenterology. 1995; 108: 1396-1404
        • Hugot J.P.
        • Chamaillard M.
        • Zouali H.
        • Lesage S.
        • Cezard J.P.
        • Belaiche J.
        • Almer S.
        • Tysk C.
        • O’Morain C.A.
        • Gassull M.
        • Binder V.
        • Finkel Y.
        • Cortot A.
        • Modigliani R.
        • Laurent-Puig P.
        • Gower-Rousseau C.
        • Macry J.
        • Colombel J.F.
        • Sahbatou M.
        • Thomas G.
        Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease.
        Nature. 2001; 411: 599-603
        • Ogura Y.
        • Bonen D.K.
        • Inohara N.
        • Nicolae D.L.
        • Chen F.F.
        • Ramos R.
        • Britton H.
        • Moran T.
        • Karaliuskas R.
        • Duerr R.H.
        • et al.
        A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease.
        Nature. 2001; 411: 603-606
        • Lala S.
        • Ogura Y.
        • Osborne C.
        • Hoor S.Y.
        • Bromfield A.
        • Davies S.
        • Ogun O.
        • Nunez G.
        • Keshav S.
        Crohn’s disease and the NOD2 gene.
        Gastroenterology. 2003; 125: 47-57
        • Gutierrez O.
        • Pipaon C.
        • Inohara N.
        • Fontalba A.
        • Ogura Y.
        • Prosper F.
        • Nunez G.
        • Fernandez-Luna J.L.
        Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.
        J Biol Chem. 2002; 277: 41701-41705
        • O’Riordan M.
        • Yi C.H.
        • Gonzales R.
        • Lee K.D.
        • Portnoy D.A.
        Innate recognition of bacteria by a macrophage cytosolic surveillance pathway.
        Proc Natl Acad Sci U S A. 2002; 99: 13861-13866
        • Inohara N.
        • Ogura Y.
        • Fontalba A.
        • Gutierrez O.
        • Pons F.
        • Crespo J.
        • Fukase K.
        • Inamura S.
        • Kusumoto S.
        • Hashimoto M.
        • et al.
        Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease.
        J Biol Chem. 2003; 278: 5509-5512
        • Chamaillard M.
        • Philpott D.
        • Girardin S.E.
        • Zouali H.
        • Lesage S.
        • Chareyre F.
        • Bui T.H.
        • Giovannini M.
        • Zaehringer U.
        • Penard-Lacronique V.
        • et al.
        Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.
        Proc Natl Acad Sci U S A. 2003; 100: 3455-3460
        • Girardin S.E.
        • Boneca I.G.
        • Viala J.
        • Chamaillard M.
        • Labigne A.
        • Thomas G.
        • Philpott D.J.
        • Sansonetti P.J.
        Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
        J Biol Chem. 2003; 278: 8869-8872
        • Ahnen D.J.
        Gastrointestinal malignancies in inflammatory bowel disease.
        in: Kirsner J.B. Inflammatory bowel disease. (5th ed). Saunders, Philadelphia2000: 379-396
        • Rhodes J.M.
        • Campbell B.J.
        Inflammation and colorectal cancer.
        Trends Mol Med. 2002; 8: 10-16
        • Swidsinski A.
        • Khilkin M.
        • Kerjaschki D.
        • Schreiber S.
        • Ortner M.
        • Weber J.
        • Lochs H.
        Association between intraepithelial Escherichia coli and colorectal cancer.
        Gastroenterology. 1998; 115: 281-286
        • Klemm P.
        • Schembri M.A.
        Bacterial adhesins.
        Int J Med Microbiol. 2000; 290: 27-35
        • Soto G.E.
        • Hultgren S.J.
        Bacterial adhesins.
        J Bacteriol. 1999; 181: 1059-1071
        • Henry S.M.
        Molecular diversity in the biosynthesis of GI tract glycoconjugates. A blood-group-related chart of microorganism receptors.
        Transfus Clin Biol. 2001; 8: 226-230
        • Campbell B.J.
        • Finnie I.
        • Hounsell E.
        • Rhodes J.M.
        Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
        J Clin Invest. 1995; 95: 571-576
        • Campbell B.J.
        • Yu L.-G.
        • Rhodes J.M.
        Altered glycosylation in inflammatory bowel disease.
        Glycoconj J. 2001; 18: 851-858
        • Hakomori S.
        Glycosylation defining cancer malignancy.
        Proc Natl Acad Sci U S A. 2002; 99: 10231-10233
        • Kim Y.S.
        • Gum Jr, J.
        • Brockhausen I.
        Mucin glycoproteins in neoplasia.
        Glycoconj J. 1996; 13: 693-707
        • Ryder S.
        • Parker N.
        • Eccleston D.
        • Haqqani M.T.
        • Rhodes J.M.
        Peanut lectin stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon cancer.
        Gastroenterology. 1994; 106: 117-124
        • Ryder S.D.
        • Jacyna M.R.
        • Levi A.J.
        • Rizzi P.M.
        • Rhodes J.M.
        Peanut ingestion increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor.
        Gastroenterology. 1998; 114: 44-49
        • Rhodes J.M.
        Unifying hypothesis for inflammatory bowel disease and associated colon cancer.
        Lancet. 1996; 347: 40-44
        • Daigle F.
        • Harel J.
        • Fairbrother J.M.
        • Lebel P.
        Expression and detection of pap-, sfa-, and afa-encoded fimbrial adhesin systems among uropathogenic Escherichia coli.
        Can J Microbiol. 1994; 40: 286-291
        • Tsen H.Y.
        • Jian L.Z.
        Development and use of a multiplex PCR system for the rapid screening of heat labile toxin I, heat stable toxin II and shiga-like toxin I and II genes of Escherichia coli in water.
        J Appl Microbiol. 1998; 84: 585-592
        • Pass M.A.
        • Odedra R.
        • Batt R.M.
        Multiplex PCRs for identification of Escherichia coli virulence genes.
        J Clin Microbiol. 2000; 38: 2001-2004
        • Barrett T.J.
        • Lior H.
        • Green J.H.
        • Khakhria R.
        • Wells J.G.
        • Bell B.P.
        • Greene K.D.
        • Lewis J.
        • Griffin P.M.
        Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157.
        J Clin Microbiol. 1994; 32: 3013-3017
        • Le Bouguenec C.
        • Lalioui L.
        • du Merle L.
        • Jouve M.
        • Courcoux P.
        • Bouzari S.
        • Selvarangan R.
        • Nowicki B.J.
        • Germani Y.
        • Andremont A.
        • et al.
        Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates.
        J Clin Microbiol. 2001; 39: 1738-1745
        • Thomas W.
        • Ascott Z.K.
        • Harmey D.
        • Slice L.W.
        • Rozengurt E.
        • Lax A.J.
        Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene.
        Infect Immun. 2001; 69: 6839-6845
        • Schultsz C.
        • Moussa M.
        • van Ketel R.
        • Tytgat G.N.J.
        • Dankert J.
        Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls.
        J Clin Pathol. 1997; 50: 573-579
        • Burke D.A.
        • Axon A.T.R.
        Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.
        Br Med J. 1988; 297: 102-104
        • Giaffer M.H.
        • Holdsworth C.D.
        • Duerden B.I.
        Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
        Gut. 1992; 33: 646-650
        • Fujita H.
        • Eishi Y.
        • Ishige I.
        • Saitoh K.
        • Takizawa T.
        • Arima T.
        • Koike M.
        Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases.
        J Gastroenterol. 2002; 37: 509-516
        • Yamamato T.
        • Endo S.
        • Yokota T.
        • Echeverria P.
        Characteristics of adherence of enteroaggregative Escherichia coli to human and animal mucosa.
        Infect Immun. 1991; 59: 3722-3739
        • Hisamatsu T.
        • Suzuki M.
        • Reinecker H.C.
        • Nadeau W.J.
        • McCormick B.A.
        • Podolsky D.K.
        CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells.
        Gastroenterology. 2003; 124: 993-1000
        • Isaacs D.
        • Wright V.M.
        • Shaw D.G.
        • Raafat F.
        • Walker-Smith J.A.
        Chronic granulomatous disease mimicking Crohn’s disease.
        J Pediatr Gastroenterol Nutr. 1985; 4: 498-501
        • Couper R.
        • Kapelushnik J.
        • Griffiths A.M.
        Neutrophil dysfunction in glycogen storage disease Ib.
        Gastroenterology. 1991; 100: 549-554
        • King Jr, T.E.
        • Savici D.
        • Campbell P.A.
        Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages.
        J Infect Dis. 1988; 158: 1309-1316
        • Hand W.L.
        • King-Thompson N.
        • Holman J.W.
        Entry of roxithromycin (RU965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes.
        Antimicrob Agents Chemother. 1987; 31: 1553-1557
        • Dawsey S.M.
        • Mark S.D.
        • Taylor P.R.
        • Limburg P.J.
        Gastric cancer and H pylori.
        Gut. 2002; 51: 457-458
        • Cebra J.J.
        Influences of microbiota on intestinal immune system development.
        Am J Clin Nutr. 1999; 69: 1046S-1051S
        • Wehkamp J.
        • Fellermann K.
        • Herrlinger K.R.
        • Baxmann S.
        • Schmidt K.
        • Schwind B.
        • Duchrow M.
        • Wohlschlager C.
        • Feller A.C.
        • Stange E.F.
        Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
        Eur J Gastroenterol Hepatol. 2002; 14: 745-752
        • Rath H.C.
        • Wilson K.H.
        • Sartor R.B.
        Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
        Infect Immun. 1999; 67: 2969-2974
        • Leiper K.
        • Campbell B.J.
        • Jenkinson M.D.
        • Milton J.
        • Yu L.G.
        • Democratis J.
        • Rhodes J.M.
        Interaction between bacterial peptides, neutrophils and goblet cells.
        Clin Sci. 2001; 101: 395-402
        • Anton P.
        • O’Connell J.
        • O’Connell D.
        • Whitaker L.
        • O’Sullivan G.C.
        • Collins J.K.
        • Shanahan F.
        Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).
        Gut. 1998; 42: 374-379
        • Rhen M.
        • Vaisanen-Rhen V.
        • Saraste M.
        • Korhonen T.K.
        Organization of genes expressing the blood-group-M-specific haemagglutinin of Escherichia coli.
        Gene. 1986; 49: 351-360
        • Gerken T.A.
        • Butenhof K.J.
        • Shogren R.
        Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins.
        Biochemistry. 1989; 28: 5536-5543
        • Karlen P.
        • Young E.
        • Brostrom O.
        • Lofberg R.
        • Tribukait B.
        • Ost K.
        • Bodian C.
        • Itzkowitz S.
        Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis.
        Gastroenterology. 1998; 115: 1395-1404
        • Chai W.
        • Hounsell E.F.
        • Cashmore G.C.
        • Rosankiewicz J.R.
        • Feeney J.
        • Lawson A.M.
        Characterisation by mass spectrometry and 1H-NMR of novel hexasaccharides among the acidic O-linked carbohydrate chains of bovine submaxillary mucin.
        Eur J Biochem. 1992; 207: 973-980
        • Rabbani G.H.
        • Teka T.
        • Zaman B.
        • Majid N.
        • Khatun M.
        • Fuchs G.J.
        Clinical studies in persistent diarrhea.
        Gastroenterology. 2001; 121: 554-560

      Linked Article